RBC Europe’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-77
Closed -$7K 678
2021
Q4
$7K Buy
77
+33
+75% +$2.8K ﹤0.01% 549
2021
Q3
$3.41K Hold
44
﹤0.01% 1081
2021
Q2
$3.15K Hold
44
﹤0.01% 1088
2021
Q1
$2.98K Hold
44
﹤0.01% 1044
2020
Q4
$3.22K Hold
44
﹤0.01% 1017
2020
Q3
$3.08K Hold
44
﹤0.01% 951
2020
Q2
$3.2K Hold
44
﹤0.01% 912
2020
Q1
$2.72K Sell
44
-67
-60% -$4.09K ﹤0.01% 887
2019
Q4
$7.26K Hold
111
﹤0.01% 855
2019
Q3
$8.78K Hold
111
﹤0.01% 814
2019
Q2
$6.41K Hold
111
﹤0.01% 881
2019
Q1
$5.82K Hold
111
﹤0.01% 909
2018
Q4
$5.87K Buy
111
+67
+152% +$3.83K ﹤0.01% 899
2018
Q3
$2.79K Buy
+44
New +$2.85K ﹤0.01% 1026

Other funds holding CONE

RBC Europe's CONE Position: Q1 2022 in Review

RBC Europe sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 77 shares — an estimated $7K sold.

RBC Europe first reported a position in CONE in Q3 2018 and held it in 14 quarters. The position peaked at $8.78K in Q3 2019. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • RBC Europe reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • RBC Europe sold 77 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $7K.
  • RBC Europe first reported a position in CyrusOne Inc Common Stock in Q3 2018 and held it in 14 quarters.
  • RBC Europe's CyrusOne Inc Common Stock position peaked at $8.78K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on RBC Europe's 13F filing for Q1 2022, filed 14 Nov 2022.